Human cancer stem cells are a target for cancer prevention using (−)-epigallocatechin gallate Hirota FujikiEisaburo SueokaMasami Suganuma Review – Cancer Research Open access 23 September 2017 Pages: 2401 - 2412
Fibrinogen promotes malignant biological tumor behavior involving epithelial–mesenchymal transition via the p-AKT/p-mTOR pathway in esophageal squamous cell carcinoma Fei ZhangYun WangYu-hong Li Original Article – Cancer Research 11 August 2017 Pages: 2413 - 2424
Traditional Chinese medicine as adjunctive therapy improves the long-term survival of lung cancer patients Yueh-Hsiang LiaoChia-Ing LiTsai-Chung Li Original Article – Cancer Research 12 August 2017 Pages: 2425 - 2435
TLR9 gene polymorphism −1486T/C (rs187084) is associated with uterine cervical neoplasm in Mexican female population Cecilia Martínez-CamposMargarita Bahena-RománVicente Madrid-Marina Original Article – Cancer Research 17 August 2017 Pages: 2437 - 2445
Targeted next-generation sequencing for analyzing the genetic alterations in atypical adenomatous hyperplasia and adenocarcinoma in situ Xuan XuNa LiJie Zhang Original Article – Cancer Research 18 August 2017 Pages: 2447 - 2453
Systemic Inflammation Response Index (SIRI), cancer stem cells and survival of localised gastric adenocarcinoma after curative resection Sen LiXiuwen LanYingwei Xue Original Article – Cancer Research 21 August 2017 Pages: 2455 - 2468
Modifiable health-related factors (smoking, physical activity and body mass index) and health care use and costs among adult cancer survivors Sapna KaulJaqueline C. AvilaYong-Fang Kuo Original Article – Cancer Research 22 August 2017 Pages: 2469 - 2480
The more from East-Asian, the better: risk prediction of colorectal cancer risk by GWAS-identified SNPs among Japanese Makiko AbeHidemi ItoKeitaro Matsuo Original Article – Cancer Research 28 August 2017 Pages: 2481 - 2492
Karyopherin α-2 is a reliable marker for identification of patients with high-risk stage II colorectal cancer Dongjun JeongHyeongjoo KimMoo-Jun Baek Original Article – Cancer Research 05 September 2017 Pages: 2493 - 2503
Prognostic role of progesterone receptor expression in a population-based analysis Adele CaldarellaAlessandro Barchielli Original Article – Cancer Research 09 September 2017 Pages: 2505 - 2509
Only SETBP1 hotspot mutations are associated with refractory disease in myeloid malignancies Nils WinkelmannVivien SchäferThomas Ernst Original Article – Cancer Research 14 September 2017 Pages: 2511 - 2519
Meeting report of the 6th Heidelberg Myeloma Workshop: current status and developments in diagnosis and therapy of multiple myeloma Maximilian MerzMarc S. RaabJens Hillengass Special Issue Manuscript 26 June 2017 Pages: 2521 - 2526
Tumor response assessment: comparison between unstructured free text reporting in routine clinical workflow and computer-aided evaluation based on RECIST 1.1 criteria Juliane GoebelJulia HoischenKai Nassenstein Original Article – Clinical Oncology 19 August 2017 Pages: 2527 - 2533
Can complementary medicine increase adherence to chemotherapy dosing protocol? A controlled study in an integrative oncology setting Ilanit Shalom-SharabiOfer LavieEran Ben-Arye Original Article – Clinical Oncology 20 August 2017 Pages: 2535 - 2543
Lenalidomide in combination with bendamustine and prednisolone in relapsed/refractory multiple myeloma: results of a phase 2 clinical trial (OSHO-#077) Juliane BeckAndreas SchwarzerWolfram Pönisch Original Article – Clinical Oncology 21 August 2017 Pages: 2545 - 2553
Survival benefit of pelvic and paraaortic lymphadenectomy in high-grade endometrial carcinoma: a retrospective population-based cohort analysis Thomas PapathemelisS. ScharlM. Klinkhammer-Schalke Original Article – Clinical Oncology 24 August 2017 Pages: 2555 - 2562
Prognostic stratification of patients with metastatic nasopharyngeal carcinoma using a clinical and biochemical scoring system Jeremy CheeKwok Seng LohChwee Ming Lim Original Article – Clinical Oncology 28 August 2017 Pages: 2563 - 2570
Identification of prognostic markers of high grade prostate cancer through an integrated bioinformatics approach Hai HuangQin ZhangWen-Hui Liu Original Article – Clinical Oncology 28 August 2017 Pages: 2571 - 2579
Safety of intraoperative chemotherapy with 5-FU for colorectal cancer patients receiving curative resection: a randomized, multicenter, prospective, phase III IOCCRC trial (IOCCRC) Rong-xin ZhangJun-zhong LinZhi-zhong Pan Original Article – Clinical Oncology 28 August 2017 Pages: 2581 - 2593
Validity of eleven prognostic scores with respect to intra- and extrahepatic recurrence of hepatocellular carcinoma after liver transplantation A. BauschkeA. Altendorf-HofmannU. Settmacher Original Article – Clinical Oncology 28 August 2017 Pages: 2595 - 2605
Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment Mao LinShuzhen LiangKecheng Xu Original Article – Clinical Oncology 04 September 2017 Pages: 2607 - 2618
Higher out-of-pocket expenses for tyrosine kinase-inhibitor therapy is associated with worse health-related quality-of-life in persons with chronic myeloid leukemia Qian JiangHaibo WangRobert Peter Gale Original Article – Clinical Oncology 11 September 2017 Pages: 2619 - 2630
To block it, or not to block it? Artur Wnorowski Letter to the Editor Open access 27 March 2017 Pages: 2631 - 2633
Assessing risk factors of acute kidney injury after liver transplantation Gui-Zhen YangFu-Shan XueHui-Xian Li Letter to the Editor 17 August 2017 Pages: 2635 - 2636
Image-guided ablations in patients with thyroid tumors Valerio FerraraCiriaco BuonomennaGiovanni Mauri Letter to the Editor 02 September 2017 Pages: 2637 - 2639